they were associated with erythema (43% of photosensitivity reactions), bullous eruption (22%), eczema (5%), desquamation (10%), necrosis (5%), and cheilitis (5%). In one case, drug-induced lupus ...
Dupilumab has been accepted for priority review by the US Food and Drug Administration (FDA) for the treatment of bullous pemphigoid (BP) in adults, according to a press release from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback